Discounted Cash Flow Rating

Buy

Return on Equity Rating

Sell

Debt to Equity Rating

Neutral

Price to Earnings Rating

Strong Buy

Analyst Rating

Buy

Simple Moving Average

Strong Buy

Exponential Moving Average

Strong Buy

Relative Strength Index

Buy

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Neutral

Insider Trading

Buy

Wall Street Data Solutions Rating

Buy

A

Twist Bioscience Corporation Common Stock (TWST)

Biological Products, (no Disgnostic Substances)

https://www.twistbioscience.com

Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well-plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies and powers cost-effective, rapid high-throughput synthesis, enabling researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of its revenue from the United States.

681 GATEWAY BLVD.
SOUTH SAN FRANCISCO, CA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

10/31/2018

Market Cap

2,569,581,960

Shares Outstanding

57,780,000

Weighted SO

57,779,033

Total Employees

N/A

Upcoming Earnings

11/15/2024

Similar Tickers

PSNL --.--%

NTRA --.--%

GH --.--%

CSTL --.--%

IQV --.--%

MTD --.--%

WAT --.--%

ICLR --.--%

Beta

1.7980

Last Div

0.0000

Range

14.42-60.9

Chg

-1.1400

Avg Vol

1097362

Mkt Cap

2569581960

Exch

NASDAQ

Country

US

Phone

800 719 0671

DCF Diff

6.1143

DCF

35.2643

Div Yield

0.0000

P/S

8.7043

EV Multiple

-15.7025

P/FV

5.1925

Div Yield %

0.0000

P/E

-11.5755

PEG

-0.2479

Payout

0.0000

Current Ratio

4.9057

Quick Ratio

4.5195

Cash Ratio

3.2423

DSO

40.7866

DIO

59.2156

Op Cycle

100.0022

DPO

13.7748

CCC

86.2274

Gross Margin

0.4053

Op Margin

-0.6435

Pretax Margin

-0.7448

Net Margin

-0.7463

Eff Tax Rate

-0.0020

ROA

-0.3453

ROE

-0.3891

ROCE

-0.3366

NI/EBT

1.0020

EBT/EBIT

1.1574

EBIT/Rev

-0.6435

Debt Ratio

0.1366

D/E

0.1775

LT Debt/Cap

0.1288

Total Debt/Cap

0.1507

Int Coverage

-189969.0000

CF/Debt

-0.7969

Equity Multi

1.2993

Rec Turnover

8.9490

Pay Turnover

26.4976

Inv Turnover

6.1639

FA Turnover

1.7612

Asset Turnover

0.4626

OCF/Share

-1.1949

FCF/Share

-1.2889

Cash/Share

4.9775

OCF/Sales

-0.2354

FCF/OCF

1.0787

CF Coverage

-0.7969

ST Coverage

-4.7735

CapEx Coverage

-12.7086

Div&CapEx Cov

-12.7086

P/BV

5.1925

P/B

5.1925

P/S

8.7043

P/E

-11.5755

P/FCF

-34.2862

P/OCF

-36.7057

P/CF

-36.7057

PEG

-0.2479

P/S

8.7043

EV Multiple

-15.7025

P/FV

5.1925

DPS

0.0000

Latest Headlines (EST)

Benzinga Sep 15, 23:08 Coeur Mining, Medical Properties Trust And RH Are Among Top 7 Mid Cap Stock Gainers Last Week (Sep 8-Sep 14): Are The Others In Your Portfolio? Benzinga Jan 17, 15:21 Goldman Sachs Upgrades Twist Bioscience, Says Express Genes Launch Will Drive Margin Expansion Benzinga Nov 17, 13:01 Why Dolby Laboratories Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Revenue Product Segmentation